Home/Filings/4/0001415889-25-016724
4//SEC Filing

Quart Barry D 4

Accession 0001415889-25-016724

CIK 0001730430other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:35 PM ET

Size

19.3 KB

Accession

0001415889-25-016724

Insider Transaction Report

Form 4
Period: 2025-06-09
Transactions
  • Sale

    Class A Ordinary Share

    2025-06-09$30.26/sh6,900$208,79412,546 total
  • Sale

    Class A Ordinary Share

    2025-06-10$30.36/sh8,212$249,31612,546 total
  • Exercise/Conversion

    Class A Ordinary Share

    2025-06-11$3.80/sh+12,336$46,87724,882 total
  • Exercise/Conversion

    Class A Ordinary Share

    2025-06-09$3.80/sh+6,900$26,22019,446 total
  • Exercise/Conversion

    Class A Ordinary Share

    2025-06-10$3.80/sh+8,212$31,20620,758 total
  • Exercise/Conversion

    Share Option

    2025-06-096,90020,548 total
    Exercise: $3.80Exp: 2027-06-28Class A Ordinary Share (6,900 underlying)
  • Exercise/Conversion

    Share Option

    2025-06-108,21212,336 total
    Exercise: $3.80Exp: 2027-06-28Class A Ordinary Shares (8,212 underlying)
  • Sale

    Class A Ordinary Share

    2025-06-11$30.39/sh12,336$374,89112,546 total
  • Exercise/Conversion

    Share Option

    2025-06-1112,3360 total
    Exercise: $3.80Exp: 2027-06-28Class A Ordinary Shares (12,336 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.00 and $30.52. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.28 and $30.5801. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F3]The option is fully vested and exercisable.

Issuer

Kiniksa Pharmaceuticals International, plc

CIK 0001730430

Entity typeother

Related Parties

1
  • filerCIK 0001384243

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:35 PM ET
Size
19.3 KB